AIP.NASDAQArteris, INC

8-K: Arteris Reports Record ACV Plus Royalties and Positive Free Cash Flow in Q1 2025, Updates Full Year Guidance

Sentiment:

Earnings Release


Arteris, Inc. announced strong first quarter 2025 financial results, highlighted by record annual contract value plus royalties and positive free cash flow, while also providing updated full year 2025 guidance.

Better than expectedThe company achieved record ACV plus royalties and positive free cash flow, exceeding previous performance.Revenue growth of 28% year-over-year indicates strong market adoption.The operating loss improved compared to the first quarter of 2024.

Summary

  • Arteris, Inc. reported its financial results for the first quarter ended March 31, 2025.
  • The company achieved a record annual contract value (ACV) plus royalties of $66.8 million, a 15% increase year-over-year.
  • Revenue for the quarter was $16.5 million, up 28% year-over-year.
  • The remaining performance obligation (RPO) reached a record high of $88.9 million, up 19% year-over-year.
  • Arteris generated positive free cash flow of $2.7 million.
  • The operating loss was $7.7 million, an improvement from the $9.1 million loss in the first quarter of 2024.
  • The company provided estimated second quarter and updated full year 2025 guidance, projecting ACV plus royalties between $66.0 and $70.0 million for Q2 and between $71.0 and $79.0 million for the full year.
  • Revenue is expected to be between $16.1 and $16.5 million for Q2 and between $65.0 and $71.0 million for the full year.
  • Non-GAAP operating loss is projected to be between $3.0 and $4.0 million for Q2 and between $7.0 and $14.0 million for the full year.
  • Free cash flow is expected to be between $(5.0) and $0.0 million for Q2 and between $0.0 and $8.0 million for the full year.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with record ACV, positive free cash flow, and revenue growth. While there are risks and an operating loss, the overall tone is optimistic due to strong performance and future guidance.

Positives

  • Record ACV plus royalties of $66.8 million indicates strong demand for Arteris' products.
  • Positive free cash flow of $2.7 million demonstrates improved financial health.
  • Revenue growth of 28% year-over-year signifies increasing market adoption.
  • Growing RPO of $88.9 million provides visibility into future revenue.
  • Expansion in the automotive market with the addition of another top global OEM shows success in a key vertical.
  • Joining the Intel Foundry Accelerator program enhances ecosystem partnerships.
  • Opening a new engineering center in Poland supports development and customer support.

Negatives

  • The company reported an operating loss of $7.7 million, although this is an improvement from the previous year.
  • The guidance for Q2 2025 indicates a potential decrease in free cash flow, ranging from $(5.0) million to $0.0 million.

Risks

  • The company faces significant competition from larger companies and third-party providers.
  • Arteris has a history of net losses.
  • The company's performance depends on the adoption of its solutions by semiconductor companies in various markets.
  • Macro-economic conditions and geopolitical conflicts could adversely impact the company and its customers.
  • The company is exposed to regulatory, operational, financial, and political risks due to its dependence on international customers and operations.
  • The company's ability to protect its proprietary technology and inventions is crucial.

Future Outlook

Arteris expects Q2 2025 ACV plus royalties to be between $66.0 and $70.0 million, revenue between $16.1 and $16.5 million, Non-GAAP operating loss between $3.0 and $4.0 million, and free cash flow between $(5.0) and $0.0 million. For the full year 2025, the company expects ACV plus royalties to be between $71.0 and $79.0 million, revenue between $65.0 and $71.0 million, Non-GAAP operating loss between $7.0 and $14.0 million, and free cash flow between $0.0 and $8.0 million.

Management Comments

  • K. Charles Janac, President and CEO of Arteris, stated that the company delivered record annual contract value plus royalties and generated positive free cash flow, driven by sustained demand.
  • Janac believes that Arteris' deepening relationships with leading global innovators and strong product offering positions the company well for long-term growth.
  • Janac noted the strength of the deal pipeline and increasing interest among major customers to expand their outsourcing to the commercial market for semiconductor System IP products.

Industry Context

Arteris' results reflect the ongoing demand for commercial semiconductor System IP products, particularly in enterprise computing, communications, and automotive sectors. The increasing adoption of chiplets and AI compute is driving further growth in these markets. Arteris' participation in the Intel Foundry Accelerator program positions it to capitalize on the growing trend of multi-die silicon solutions.

Comparison to Industry Standards

  • Arteris competes with companies like Synopsys, Cadence, and Arm in the system IP market.
  • The 15% year-over-year growth in ACV plus royalties is a positive indicator compared to industry averages.
  • The positive free cash flow distinguishes Arteris from some competitors who may still be operating at a loss.
  • The expansion into the automotive OEM market aligns with the industry trend of increasing semiconductor content in vehicles.

Stakeholder Impact

  • Shareholders will likely react positively to the record ACV and positive free cash flow.
  • Employees may be encouraged by the company's growth and expansion.
  • Customers will benefit from Arteris' continued innovation and support.
  • Suppliers may see increased demand for their products and services.
  • Creditors may view Arteris as a more creditworthy borrower.

Next Steps

  • Arteris will host a conference call on May 13, 2025, to review its first quarter 2025 financial results and discuss its financial outlook.
  • The company will continue to focus on deepening relationships with leading global innovators and expanding its product offerings.
  • Arteris will work to capitalize on the growing demand for semiconductor System IP products in key vertical markets.

Key Dates

DateDescription
2004-2025Copyright period for Arteris, Inc.
March 31, 2025End of the first quarter for which financial results are reported.
May 13, 2025Date of the press release and conference call to discuss Q1 2025 financial results.

Keywords

Arteris, System IP, Semiconductor, ACV, Royalties, Financial Results, Guidance, RPO, Free Cash Flow, Automotive, Intel Foundry Accelerator, Chiplets, AI, ADAS

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.